Search results
15 paź 2020 · Improvements in pre-clinical and clinical care are likely to underpin successful stroke treatment, recovery, rehabilitation and prevention. In this review, we focus on the pathophysiology of stroke, major advances in the identification of therapeutic targets and recent trends in stroke research.
- Open in a Separate Window
Embolic stroke model : Mimics the pathogenesis of human...
- Figure 1
Stroke is the second leading cause of death and a major...
- PMC Free Article
Stroke is the leading cause of long-term adult disability...
- 1332 Consecutive Cases
Introduction. Stroke is a major cause of death and adult...
- PMC6476045
1. Introduction. An ischemic stroke is a transient or...
- Update on Dual Antiplatelet Therapy for Secondary Stroke Prevention
Furthermore, in a one-year outcome follow-up study, the...
- Role of Perinatal Inflammation in Neonatal Arterial Ischemic Stroke
Inflammatory markers are found as risk factors of NAIS in...
- Utstein Recommendation for Emergency Stroke Care
Background. Stroke is a major cause of death and disability...
- Open in a Separate Window
The purpose of this review article is to highlight the inflammation-mediated secondary cell death that plagues both brain and spleen in stroke and to evaluate the therapeutic potential of stem cell therapy in dampening these inflammatory responses.
8 mar 2022 · The increased shear stress on the endothelium contributes to the induction of atherosclerosis and carotid stenosis. These disease phenotypic manifestations have led to specific treatments to reduce stroke risk in the context of atrial fibrillation or carotid atherosclerosis.
20 lis 2023 · In this large, hospital‐based Florida Stroke Registry, we have demonstrated racial and ethnic disparities in BP‐guideline adherence to antihypertensive guideline‐based treatments in real‐world acute stroke cases.
10 paź 2019 · This Primer by Campbell and colleagues discusses the epidemiology, mechanisms, diagnosis, prevention and treatment of ischaemic stroke.
4 mar 2024 · Despite its health and socioeconomic burden, there is still minimal availability of effective pharmacological therapies for its treatment. In this review, we take an in-depth look at the etiology and pathophysiology of ischemic stroke, including molecular and cellular changes.
3 paź 2023 · In their review, Chung Yang Yeh et al. review the available results of recent clinical trials for acute ischemic stroke treatment with both a thrombolytic agent and MT, and evaluate trials on neuroprotective agents, with particular attention paid to the role of voltage-gated potassium channel Kv2.1 for neuroprotection . The authors conclude ...
